By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11 rue de MOLSHEIM, 67082
Cedex      France
Phone: 011-33-3-88-27-91-21 Fax: 011-33-3-88-27-91-11



Gene Therapy


Human Genome Sciences, Inc.  Gene Therapy Partnerships

Company News
TRANSGENE (ENX:TNG) Announces Financial Calendar For 2015 1/8/2015 10:51:20 AM
TRANSGENE (ENX:TNG) Announces Events Calendar For Fourth Quarter 2014 10/29/2014 8:56:35 AM
TRANSGENE (ENX:TNG) Announces Third Quarter 2014 Financial Results 10/22/2014 9:36:46 AM
TRANSGENE (ENX:TNG) Announces Management Changes 10/9/2014 10:58:35 AM
TRANSGENE (ENX:TNG) Presents Additional Positive Clinical Data From Phase 2b Part Of TIME Trial With TG4010 At ESMO 9/29/2014 9:52:48 AM
TRANSGENE (ENX:TNG) Appoints Eric Quéméneur, PhD As Executive Vice President In Charge Of Research & Development 9/23/2014 11:50:10 AM
TRANSGENE (ENX:TNG) Reports Financial Results For First Six Months Of 2014 And Provides Update On TG4010 9/9/2014 11:18:42 AM
TRANSGENE (ENX:TNG)-Tasly Pharmaceutical JV Reports Immunotherapy Progress 7/2/2014 11:52:19 AM
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014 10:46:07 AM
TRANSGENE (ENX:TNG) Announces Promising Results In An Update From The Phase 2b Part Of TIME Trial With TG4010 In Advanced Non-Small Cell Lung Cancer 5/27/2014 10:40:15 AM